Lipopolysaccharide Binding Protein Binds to Triacylated and Diacylated Lipopeptides and Mediates Innate Immune Responses

[1]  S. Akira,et al.  Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.

[2]  L. Kremer,et al.  Lipomannans, But Not Lipoarabinomannans, Purified from Mycobacterium chelonae and Mycobacterium kansasii Induce TNF-α and IL-8 Secretion by a CD14-Toll-Like Receptor 2-Dependent Mechanism1 , 2003, The Journal of Immunology.

[3]  E. Tuomanen,et al.  Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. , 2003, Immunity.

[4]  P. Tobias,et al.  Lipopolysaccharide (LPS)-binding Protein Inhibits Responses to Cell-bound LPS* , 2003, Journal of Biological Chemistry.

[5]  U. Göbel,et al.  Lipoteichoic Acid (LTA) of Streptococcus pneumoniaeand Staphylococcus aureus Activates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved* , 2003, The Journal of Biological Chemistry.

[6]  S. Akira,et al.  Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.

[7]  A. Nesburn,et al.  Lipopeptide vaccines--yesterday, today, and tomorrow. , 2002, The Lancet. Infectious diseases.

[8]  Thomas Hartung,et al.  Cytokine induction by purified lipoteichoic acids from various bacterial species – Role of LBP, sCD14, CD14 and failure to induce IL‐12 and subsequent IFN‐γ release , 2002, European journal of immunology.

[9]  K. Wegscheider,et al.  High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. , 2001, Blood.

[10]  M. Arditi,et al.  Cooperation of Toll-Like Receptor 2 and 6 for Cellular Activation by Soluble Tuberculosis Factor and Borrelia burgdorferi Outer Surface Protein A Lipoprotein: Role of Toll-Interacting Protein and IL-1 Receptor Signaling Molecules in Toll-Like Receptor 2 Signaling1 , 2001, The Journal of Immunology.

[11]  S. Akira,et al.  Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.

[12]  U. Göbel,et al.  Toll-like Receptor-2 Mediates Treponema Glycolipid and Lipoteichoic Acid-induced NF-κB Translocation* , 2001, The Journal of Biological Chemistry.

[13]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  U. Göbel,et al.  Involvement of Lipopolysaccharide Binding Protein, CD14, and Toll-Like Receptors in the Initiation of Innate Immune Responses by Treponema Glycolipids1 , 2000, The Journal of Immunology.

[15]  D. Golenbock,et al.  Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products* , 1999, The Journal of Biological Chemistry.

[16]  W. Buurman,et al.  Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. , 1999, Journal of immunology.

[17]  R. M. Wooten,et al.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. , 1999, Journal of immunology.

[18]  B. Bloom,et al.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.

[19]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[20]  B. Monks,et al.  Cutting edge: cells that carry A null allele for toll-like receptor 2 are capable of responding to endotoxin. , 1999, Journal of immunology.

[21]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[22]  S. Roman-Roman,et al.  Signal transduction pathways involved in the activation of NF-kappa B, AP-1, and c-fos by Mycoplasma fermentans membrane lipoproteins in macrophages. , 1999, Journal of immunology.

[23]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[24]  M. Rothe,et al.  Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide , 1998, The Journal of experimental medicine.

[25]  G. Jung,et al.  Structure and Specific Activity of Macrophage-Stimulating Lipopeptides from Mycoplasma hyorhinis , 1998, Infection and Immunity.

[26]  A. Gurney,et al.  Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling , 1998, Nature.

[27]  C. Schmid,et al.  Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. , 1998, The New England journal of medicine.

[28]  J. Radolf,et al.  Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. , 1998, Journal of immunology.

[29]  R. Schumann,et al.  LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. , 1998, The Journal of clinical investigation.

[30]  R. Tapping,et al.  Binding of Bacterial Peptidoglycan to CD14* , 1998, The Journal of Biological Chemistry.

[31]  R. Schumann,et al.  Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. , 1997, Genomics.

[32]  A. Hoess,et al.  Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. , 1997, Journal of immunology.

[33]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[34]  G. Rune,et al.  Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection , 1997, Nature.

[35]  K. Mittenbühler,et al.  Bacterial cell wall components as immunomodulators--I. Lipopeptides as adjuvants for parenteral and oral immunization. , 1997, International journal of immunopharmacology.

[36]  G. Jung,et al.  Isolation, Structure Elucidation, and Synthesis of a Macrophage Stimulatory Lipopeptide from Mycoplasma fermentans Acting at Picomolar Concentration , 1997, The Journal of experimental medicine.

[37]  H. Flad,et al.  Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes , 1997, Infection and immunity.

[38]  F. Herrmann,et al.  Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. , 1996, Journal of immunology.

[39]  F. Herrmann,et al.  The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins , 1996, Molecular and cellular biology.

[40]  P. Mühlradt,et al.  Identification of S-(2,3-dihydroxypropyl)cystein in a macrophage-activating lipopeptide from Mycoplasma fermentans. , 1996, Biochemistry.

[41]  L. Davis,et al.  Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. , 1995, Journal of immunology.

[42]  J. Weis,et al.  Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification , 1994, Infection and immunity.

[43]  D. Beezhold,et al.  A 48-kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytes , 1994, Infection and immunity.

[44]  A. Tomasz,et al.  CD14 is a pattern recognition receptor. , 1994, Immunity.

[45]  F. Herrmann,et al.  Lipopolysaccharide binding protein: its role and therapeutical potential in inflammation and sepsis. , 1994, Biochemical Society transactions.

[46]  J. Weis,et al.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties , 1993, Infection and immunity.

[47]  M. Glauser,et al.  Septic shock: pathogenesis , 1991, The Lancet.

[48]  R. Ulevitch,et al.  Structure and function of lipopolysaccharide binding protein. , 1990, Science.

[49]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[50]  J. Radolf,et al.  Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins , 1990, Infection and immunity.

[51]  M. L. Le Beau,et al.  The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. , 1988, Science.

[52]  K. Anderson,et al.  The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein , 1988, Cell.

[53]  J. Gilsdorf,et al.  Community-acquired pneumonia in children. , 1987, Seminars in respiratory infections.

[54]  A. Schneider,et al.  Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. , 1979, The Journal of biological chemistry.

[55]  V. Braun,et al.  Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall. The specific effect of trypsin on the membrane structure. , 1969, European journal of biochemistry.

[56]  藤田 真理.  Involvement of leucine residues at positions 107, 112, and 115 in a leucine-rich repeat motif of human Toll-like receptor 2 in the recognition of diacylated lipoproteins and lipopeptides and Staphylococcus aureus peptidoglycans , 2005 .

[57]  R. Tapping,et al.  Soluble CD14-mediated cellular responses to lipopolysaccharide. , 2000, Chemical immunology.

[58]  E. Wouters,et al.  Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. , 2000, American journal of respiratory cell and molecular biology.

[59]  J. Strominger,et al.  Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigen , 1986, European journal of immunology.